![](/img/cover-not-exists.png)
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone
Zagon, Ian S, Sassani, Joseph W, Immonen, Jessica A, McLaughlin, Patricia JVolume:
42
Language:
english
Journal:
Clinical & Experimental Ophthalmology
DOI:
10.1111/ceo.12144
Date:
March, 2014
File:
PDF, 509 KB
english, 2014